Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis.
作者信息
Sathish Thirunavukkarasu, Kapoor Nitin, Cao Yingting, Tapp Robyn J, Zimmet Paul
机构信息
Population Health Research Institute (PHRI), McMaster University, Hamilton, Ontario, Canada.
Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India.
出版信息
Diabetes Obes Metab. 2021 Mar;23(3):870-874. doi: 10.1111/dom.14269. Epub 2020 Dec 29.
Abstract
摘要
相似文献
1
Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis.新冠病毒病患者中新诊断糖尿病的比例：一项系统评价与荟萃分析
Diabetes Obes Metab. 2021 Mar;23(3):870-874. doi: 10.1111/dom.14269. Epub 2020 Dec 29.
2
Is newly diagnosed diabetes as frequent as preexisting diabetes in COVID-19 patients?新诊断出的糖尿病在新冠肺炎患者中是否与已存在的糖尿病一样常见？
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):147-148. doi: 10.1016/j.dsx.2020.12.024. Epub 2020 Dec 15.
3
Comparison of the clinical characteristics and outcomes of hospitalized adult COVID-19 and influenza patients - a prospective observational study.比较住院成人 COVID-19 和流感患者的临床特征和结局：一项前瞻性观察研究。
Infect Dis (Lond). 2021 Feb;53(2):111-121. doi: 10.1080/23744235.2020.1840623. Epub 2020 Nov 10.
4
Impact of newly diagnosed diabetes on coronavirus disease 2019 severity and hyperglycemia.新诊断糖尿病对 2019 年冠状病毒病严重程度和高血糖的影响。
J Diabetes Investig. 2022 Jun;13(6):1086-1093. doi: 10.1111/jdi.13754. Epub 2022 Feb 7.
5
Diabetes Mellitus and COVID-19: Review Article.糖尿病与 COVID-19：综述文章。
Diabetes Metab Syndr. 2021 Nov-Dec;15(6):102268. doi: 10.1016/j.dsx.2021.102268. Epub 2021 Sep 4.
6
Prevalence and impact of diabetes and cardiovascular disease on clinical outcome among patients with COVID-19 in Bangladesh.糖尿病和心血管疾病在孟加拉国新冠肺炎患者中的患病率及其对临床结局的影响。
Diabetes Metab Syndr. 2021 May-Jun;15(3):1009-1016. doi: 10.1016/j.dsx.2021.05.005. Epub 2021 May 8.
7
Impact of cardiovascular and metabolic diseases on the severity of COVID-19: a systematic review and meta-analysis.心血管和代谢疾病对新型冠状病毒肺炎严重程度的影响：一项系统综述和荟萃分析
Aging (Albany NY). 2020 Nov 16;12(22):23409-23421. doi: 10.18632/aging.103991.
8
COVID-19 in patients with hidradenitis suppurativa.化脓性汗腺炎患者中的新型冠状病毒肺炎
Br J Dermatol. 2021 Jan;184(1):182-184. doi: 10.1111/bjd.19492. Epub 2020 Sep 24.
9
The association of diabetes with COVID-19 disease severity: evidence from adjusted effect estimates.糖尿病与新冠病毒疾病严重程度的关联：来自调整后效应估计的证据。
Hormones (Athens). 2021 Jun;20(2):409-414. doi: 10.1007/s42000-020-00259-x. Epub 2020 Nov 25.
10
Asthma is associated with increased risk of intubation but not hospitalization or death in coronavirus disease 2019.哮喘与2019冠状病毒病患者插管风险增加相关，但与住院或死亡风险无关。
Ann Allergy Asthma Immunol. 2021 Jan;126(1):93-95. doi: 10.1016/j.anai.2020.10.002. Epub 2020 Oct 12.
引用本文的文献
1
The association between previous SARS-CoV-2 infection and incidence of stroke.既往新冠病毒感染与中风发病率之间的关联。
IJID Reg. 2025 Jul 28;16:100716. doi: 10.1016/j.ijregi.2025.100716. eCollection 2025 Sep.
2
Effect of obesity on the acute response to SARS-CoV-2 infection and development of post-acute sequelae of COVID-19 (PASC) in nonhuman primates.肥胖对非人灵长类动物感染SARS-CoV-2的急性反应及新冠病毒感染后急性后遗症（PASC）发展的影响。
PLoS Pathog. 2025 Jul 24;21(7):e1012988. doi: 10.1371/journal.ppat.1012988. eCollection 2025 Jul.
3
Addressing common sources of bias in studies of new-onset type 2 diabetes following COVID that use electronic health record data.解决在使用电子健康记录数据研究新冠疫情后新发2型糖尿病时常见的偏倚来源问题。
Diabet Epidemiol Manag. 2024 Apr-Jun;14. doi: 10.1016/j.deman.2023.100193. Epub 2023 Dec 14.
4
Impact of SARS-CoV-2 Infection on Disease Trajectory in Youth with T1D: An EHR-Based Cohort Study from the RECOVER Program.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染对1型糖尿病青少年疾病进程的影响：来自RECOVER项目的一项基于电子健康记录的队列研究
Pediatr Diabetes. 2023 Aug 9;2023:8798997. doi: 10.1155/2023/8798997. eCollection 2023.
5
Glycemic Control Status After Six Months in Post-COVID-19 Patients.新冠病毒感染康复患者六个月后的血糖控制状况
Cureus. 2025 Mar 26;17(3):e81225. doi: 10.7759/cureus.81225. eCollection 2025 Mar.
6
Impact of the COVID-19 Pandemic and Control Measures on Screening and Diagnoses of Type 2 Diabetes in British Columbia.新冠疫情及防控措施对不列颠哥伦比亚省2型糖尿病筛查与诊断的影响
Int J Environ Res Public Health. 2025 Mar 28;22(4):519. doi: 10.3390/ijerph22040519.
7
Increased galanin-galanin receptor 1 signaling, inflammation, and insulin resistance are associated with affective symptoms and chronic fatigue syndrome due to long COVID.加兰素-加兰素受体1信号增强、炎症和胰岛素抵抗与长期新冠导致的情感症状及慢性疲劳综合征有关。
PLoS One. 2025 Mar 6;20(3):e0316373. doi: 10.1371/journal.pone.0316373. eCollection 2025.
8
Effect of obesity on the acute response to SARS-CoV-2 infection and development of post-acute sequelae of COVID-19 (PASC) in nonhuman primates.肥胖对非人灵长类动物感染SARS-CoV-2的急性反应及新冠病毒感染后急性后遗症（PASC）发展的影响。
bioRxiv. 2025 Feb 22:2025.02.18.638792. doi: 10.1101/2025.02.18.638792.
9
Correlation of diabetes and adverse outcomes in hospitalized COVID-19 patients admitted to a tertiary hospital in China during a small-scale COVID-19 outbreak.在中国一家三级医院小规模新冠疫情爆发期间收治的住院新冠患者中，糖尿病与不良结局的相关性
PeerJ. 2025 Jan 27;13:e18865. doi: 10.7717/peerj.18865. eCollection 2025.
10
Prevalence and short-term clinical impacts of new-onset diabetes mellitus among patients with COVID-19 in jazan region, Saudi Arabia.沙特阿拉伯宰德地区 COVID-19 患者中新发糖尿病的患病率及其短期临床影响。
BMC Endocr Disord. 2024 Sep 20;24(1):197. doi: 10.1186/s12902-024-01724-z.
本文引用的文献
1
What is the role of admission HbA1c in managing COVID-19 patients?入院时糖化血红蛋白（HbA1c）在新冠病毒病（COVID-19）患者管理中起什么作用？
J Diabetes. 2021 Mar;13(3):273-275. doi: 10.1111/1753-0407.13140. Epub 2020 Dec 22.
2
Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes.2019冠状病毒病（COVID-19）与新发糖尿病之间潜在的代谢和炎症途径。
Diabetes Metab. 2021 Mar;47(2):101204. doi: 10.1016/j.diabet.2020.10.002. Epub 2020 Oct 28.
3
Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?对于新冠病毒疾病（COVID-19）的严重程度而言，新诊断出的糖尿病比已存在的糖尿病是更强的风险因素吗？
J Diabetes. 2021 Feb;13(2):177-178. doi: 10.1111/1753-0407.13125. Epub 2020 Nov 9.
4
Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia.COVID-19 患者伴发糖尿病与高血糖的临床特征。
J Diabetes Res. 2020 Aug 24;2020:3918723. doi: 10.1155/2020/3918723. eCollection 2020.
5
Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study.糖尿病患者对 SARS-CoV-2 多种抗原的抗体反应：一项观察性队列研究。
Diabetologia. 2020 Dec;63(12):2548-2558. doi: 10.1007/s00125-020-05284-4. Epub 2020 Oct 8.
6
Newly diagnosed diabetes in COVID-19 patients.新冠病毒肺炎患者新诊断出的糖尿病
Prim Care Diabetes. 2021 Feb;15(1):194. doi: 10.1016/j.pcd.2020.08.014. Epub 2020 Aug 27.
7
Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19.糖尿病作为新冠病毒病住院患者早期预后不良的一个风险因素
Diabetes Care. 2020 Dec;43(12):2938-2944. doi: 10.2337/dc20-1506. Epub 2020 Aug 26.
8
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.新诊断的糖尿病和入院时的高血糖通过加重呼吸恶化预测 COVID-19 的严重程度。
Diabetes Res Clin Pract. 2020 Oct;168:108374. doi: 10.1016/j.diabres.2020.108374. Epub 2020 Aug 15.
9
Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study.1 型和 2 型糖尿病与英格兰 COVID-19 相关死亡率的关联：一项全人群研究。
Lancet Diabetes Endocrinol. 2020 Oct;8(10):813-822. doi: 10.1016/S2213-8587(20)30272-2. Epub 2020 Aug 13.
10
COVID-19, ketoacidosis and new-onset diabetes: Are there possible cause and effect relationships among them?新型冠状病毒肺炎、酮症酸中毒与新发糖尿病：它们之间是否存在可能的因果关系？
Diabetes Obes Metab. 2020 Dec;22(12):2507-2508. doi: 10.1111/dom.14170. Epub 2020 Aug 27.
Zotero 插件